Ridus Pharmaceuticals Private Limited
About Ridus Pharmaceuticals Private Limited
Data last updated:
Ridus Pharmaceuticals Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 09 July 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24231WB1998PTC087468. Its GSTIN is 19AABCR8237Q1ZL (West Bengal).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.21 Lakh. It is led by directors Jajati Chatterjee and Subrato Chatterjee.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 24E Jyotish Roy Road, Kolkata, West Bengal, India – 700053.
As per the financials filed for FY 2025, the company reported a revenue of ₹19.74 Lakh, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹13,078 (net margin 0.7%) and EBITDA of ₹24,552 (EBITDA margin 1.2%). Revenue has declined at a compounded annual rate (CAGR) of 3% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ridus Pharmaceuticals Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address24E Jyotish Roy Road, Kolkata, West Bengal, India – 700053
- IndustryHealthcare, Other Hospital And Medical Care Activities
To see the full contact details of Ridus Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ridus Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ridus Pharmaceuticals Private Limited, buy the company report.
Financials of Ridus Pharmaceuticals Private Limited
FY 2025 filings availableRidus Pharmaceuticals Private Limited reported revenue of ₹19.74 Lakh (up 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 4% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹24,552 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13,078 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ridus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ridus Pharmaceuticals Private Limited
Ridus Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jajati Chatterjee | Director | 09 Jul 1998 | 28 Years 3 Months | Current |
| Subrato Chatterjee | Director | 09 Jul 1998 | 28 Years 3 Months | Current |
Peer comparison
Ridus Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Niyogen Pharmaceuticals Private Limited | ₹19.74 Lakh (FY 2024) | -10.0% | Sultanganj Patna, Bihar, India | |||
| Astrakind Pharmaceuticals Private Limited | ₹19.74 Lakh (FY 2024) | 275.0% | Jaipur, Rajasthan, India | |||
| Ridus Pharmaceuticals Private Limitedthis company | ₹19.74 Lakh (FY 2025) | ₹13,078 | 0.7% | 4.0% | Kolkata, West Bengal, India | |
| Artenda Pharmaceuticals Private Limited | ₹19.71 Lakh (FY 2017) | 118.0% | Chennai, Tamil Nadu, India | |||
| Loenz Pharmaceuticals (OPC) Private Limited | ₹19.71 Lakh (FY 2021) | 302.0% | Saharsa, Bihar, India | |||
| Bedrock Pharmaceuticals Private Limited | ₹19.71 Lakh (FY 2025) | 26.0% | Rudrapur, Uttarakhand, India |
To see the full peer comparison of Ridus Pharmaceuticals Private Limited, buy the company report.
Auditor
Ridus Pharmaceuticals Private Limited is audited by R.DEY & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R.DEY & ASSOCIATES | FY 2017 | 322792E |
Shareholding
The shareholding of Ridus Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Ridus Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ridus Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ridus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ridus Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AABCR8237Q1ZL | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ridus Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ridus Pharmaceuticals Private Limited has 2 board changes on record since 1998: 2 appointments. The latest: Jajati Chatterjee was appointed as Director on 09 Jul 1998.
Frequently asked questions
Ridus Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 09 July 1998 (28+ years old) and is registered under CIN U24231WB1998PTC087468.
Ridus Pharmaceuticals has 2 current directors:
- Jajati Chatterjee - Director
- Subrato Chatterjee - Director
The latest financial statements of Ridus Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Ridus Pharmaceuticals is 19AABCR8237Q1ZL, registered in West Bengal.
The CIN (Corporate Identification Number) of Ridus Pharmaceuticals is U24231WB1998PTC087468. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ridus Pharmaceuticals was incorporated on 09 July 1998, making it 28+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Ridus Pharmaceuticals by revenue are Niyogen Pharmaceuticals Private Limited, Astrakind Pharmaceuticals Private Limited, Artenda Pharmaceuticals Private Limited, Loenz Pharmaceuticals (OPC) Private Limited, Bedrock Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Jajati Chatterjee was appointed as Director on 09 Jul 1998. Subrato Chatterjee was appointed as Director on 09 Jul 1998.
The registered office of Ridus Pharmaceuticals is at 24E Jyotish Roy Road, Kolkata, West Bengal, India – 700053.
Ridus Pharmaceuticals operates in the healthcare industry, in the other hospital and medical care activities segment.
The compliance status of Ridus Pharmaceuticals is compliant as of 02 July 2026. The company is actively filing with the Registrar of Companies.